While markers like the rheumatoid factor (RF) and anti-citrullinated peptide antibody (ACPA) are known to correlate with disease activity in RA [9,10], there remains a gap in our understanding despite advancements in biochemical markers for RA-ILD [1,11]. The gene discussed is PRTN3; the disease is interstitial lung disease.